Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy.
Capelli G, Campi C, Bao QR, Morra F, Lacognata C, Zucchetta P, Cecchin D, Pucciarelli S, Spolverato G, Crimì F. Capelli G, et al. Among authors: pucciarelli s. Nucl Med Commun. 2022 Jul 1;43(7):815-822. doi: 10.1097/MNM.0000000000001570. Epub 2022 Apr 26. Nucl Med Commun. 2022. PMID: 35471653 Free PMC article.
Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
Agostini M, Pucciarelli S, Enzo MV, Del Bianco P, Briarava M, Bedin C, Maretto I, Friso ML, Lonardi S, Mescoli C, Toppan P, Urso E, Nitti D. Agostini M, et al. Among authors: pucciarelli s. Ann Surg Oncol. 2011 Sep;18(9):2461-8. doi: 10.1245/s10434-011-1638-y. Epub 2011 Mar 17. Ann Surg Oncol. 2011. PMID: 21416156
Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Pucciarelli S, Rampazzo E, Briarava M, Maretto I, Agostini M, Digito M, Keppel S, Friso ML, Lonardi S, De Paoli A, Mescoli C, Nitti D, De Rossi A. Pucciarelli S, et al. Ann Surg Oncol. 2012 Sep;19(9):3089-96. doi: 10.1245/s10434-012-2272-z. Epub 2012 Mar 7. Ann Surg Oncol. 2012. PMID: 22395986
Predictive response biomarkers in rectal cancer neoadjuvant treatment.
Agostini M, Crotti S, Bedin C, Cecchin E, Maretto I, D'Angelo E, Pucciarelli S, Nitti D. Agostini M, et al. Among authors: pucciarelli s. Front Biosci (Schol Ed). 2014 Jan 1;6(1):110-9. doi: 10.2741/s418. Front Biosci (Schol Ed). 2014. PMID: 24389265 Free article. Review.
Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients.
Maas M, Nelemans PJ, Valentini V, Crane CH, Capirci C, Rödel C, Nash GM, Kuo LJ, Glynne-Jones R, García-Aguilar J, Suárez J, Calvo FA, Pucciarelli S, Biondo S, Theodoropoulos G, Lambregts DM, Beets-Tan RG, Beets GL. Maas M, et al. Among authors: pucciarelli s. Int J Cancer. 2015 Jul 1;137(1):212-20. doi: 10.1002/ijc.29355. Epub 2014 Dec 13. Int J Cancer. 2015. PMID: 25418551 Free PMC article.
368 results